- Pfizer and Moderna are providing exaggerated information to the public about their coronavirus vaccines.
- This is having a deleterious effect on international policies for managing the coronavirus.
See our references for this article and related articles at this link.
Much has been made of the announced coronavirus vaccines by Pfizer and Moderna.
The coverage of the vaccine by the establishment media has been brainless. It simply presumes the vaccine will work and does not ask the question of how the vaccine was developed so fast.
The US Government is buying large quantities of vaccines from pharma companies without much evidence of how well they work.
Stock Speculation on Stocks of the Pharma Companies That Announced the Corona Virus Vaccines
Both executives at Pfizer and Moderna both sold large amounts of stock right after their stocks went up due to announcing vaccines for the coronavirus.
Whether the coronavirus vaccine developed by Moderna succeeds or not, executives at the small biotech company have already made tens of millions of dollars by cashing in their stock. An NPR examination of official company disclosures has revealed additional irregularities and potential warning signs.
“On a scale of one to 10, one being less concerned and 10 being the most concerned,” said Daniel Taylor, an associate professor of accounting at the Wharton School, “this is an 11.”
Taylor said Moderna’s stock-selling practices appear well outside the norm, and raise questions about the company’s internal controls to prevent insider trading.
Since January, CEO Stéphane Bancel has sold roughly $40 million worth of Moderna stock held by himself or associated investment funds; Chief Medical Officer Tal Zaks has sold around $60 million; and President Stephen Hoge has sold more than $10 million.
No clear evidence has emerged indicating that executives sold stock based on confidential internal information, which would be illegal. And as long as they don’t engage in insider trading, executives are typically free to sell company stock. – NPR
This also brings up the question of why the executives would do this if they were confident in the vaccine being effective. Moderna executives do not need to release a vaccine to make millions, they only need to make an announcement. Then later, when the vaccine does not work, they can declare that they thought it would work, but it didn’t.
And the type of stock sales look particularly suspicious as explained in the following quotation.
Here’s what NPR’s examination found:
Stock Sales Worth Tens Of Millions: Since June 1, NPR has found, company executives have sold roughly $90 million worth of Moderna stock. Rather than put a hold on the trades after facing intense criticism in May, company executives continued to sell.
Questionable Modifications To Stock Sale Plans: Moderna says its executives pre-scheduled their stock sales long in advance. Those schedules – known as 10b5-1 plans – can act as a defense to charges of insider trading. But the plans have to be put in place when executives do not have confidential inside information. NPR has found multiple executives adopted or modified their plans just before key announcements about the company’s vaccine. That has raised questions about whether they were aware of nonpublic information when they planned their stock trades.
Selling To Zero: Generally, corporate best practices suggest that a company’s leadership should hold on to at least some stock in their company to have “skin in the game.” That way, the thinking goes, an executive has an incentive to improve the company’s performance. As Moderna has been developing its coronavirus vaccine, two executives, including the Chief Medical Officer, have sold all their stock holdings in the company. The General Counsel has sold nearly all of her holdings. – NPR
Again, if the vaccine is effective, the stock price will only further rise. The selling of all stock by some of the executives indicates a lack of confidence in the vaccine. Again, Moderna need not have developing a working vaccine.
This is straight-up insider trading. And if the Moderna vaccines turns out to be ineffective, there is a strong case to prosecute the Moderna executives in my opinion. The very fact that so much is being pinned on this company, which is clearly performing a pump and dump stock scam should be a major red flag.
This fact has not been widely distributed as a news story, and when it has, it has been presented in the business press and is not included in the stories about the effectiveness of the vaccines.
This 60 minute Australia program was aired in May of 2020. In this program, professor Authur Caplan called into question the estimate of 12 months to obtain a vaccine for coronavirus. Now, in December, which is seven months after he made this statement, the virus has arrived. But does it work?
The point made by Caplan is that Moderna has never had any drug approved. Yet it is assumed that Moderna’s vaccine will be effective.
The information communicated by Caplan in this video, which explains the general duration of the development of vaccines in the past, is not being communicated to the public. Instead, the public is being fed overly optimistic projections by politicians.
Trump has been one of the politicians who has been creating an overly rosy scenario of the impact of vaccines.
The virus, they are working hard, it looks like by April it miraculously goes away.
This statement by Trump seems to presume that a vaccine for a virus can be developed in just a few months, which of course is false. Trump has been a constant source of false information about the coronavirus. Trump might be one the worst possible presidents the US could have had for dealing with a pandemic, as not only is Trump a natural salesman with little concern for evidence, but he has demonstrated a complete ignorance of biology, as we cover in the article What We Can Learn About Trump’s Advice on Drinking Lysol for Treating the Coronavirus. From his statements, it is not clear that he understands human bodies are made of cells.
The author is neither a Republican voter nor a Democratic voter and has a history of piling on large amounts of criticism on both parties. The author opposes corruption and ineptitude and calls it out no matter the country or the individual’s political affiliation.
How The FDA Not Doing its Job on the Vaccines
The FDA has been increasingly tolerant of pharmaceutical companies making claims in the press, rather than first submitting the tests to the FDA. If we have a health system that departs from the scientific method and is driven by the stock incentives of the executives in the pharmaceutical companies, we will have an unending series of false-positive results.
The negative reactions from the vaccines that are being tested are already streaming in.
Media outlets are reporting that two individuals who received the Pfizer-BioNTech COVID-19 mRNA vaccine developed severe anaphylactic reactions following the injection.
England’s National Health Service (NHS) warned Wednesday that people “with a history of a significant allergic reaction to a vaccine, medicine or food” should not be given the COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and Germany’s BioNTech. UK’s Medical and Health products Regulatory Agency, as reported by The Wall Street Journal, reminded health-care workers that vaccinations should only be carried out in facilities where resuscitation measures are available.
What is concerning about the response is the fact that in the letter we acknowledge that we had already reached out to Moderna’s scientists regarding the use of PEG and lack of informing vaccine trial recipients about the use of PEG in the vaccine, soliciting a history of PEG allergies and testing blood antibody levels to PEG.
Did the FDA officials actually read the letter?
CHD’s concerns about PEG stem from the fact that PEG-specific immune responses can actually reduce the efficacy of vaccines and increase the occurrence of adverse events.
“As Moderna’s mRNA-1273 candidate vaccine uses a PEGylated LNP vector, what procedures are included in the trial to mitigate this risk?”
The response from CovPN was as follows:
Moderna documents and publications indicate that the company is well aware of safety risks associated with PEG and other aspects of its mRNA technology. In the corporate prospectus supporting Moderna’s stock market launch in late 2018, the company was frank that its technical approach has numerous risks.
Instead of expressing concern over clinical trial participants’ welfare, that section of the prospectus concluded that any one of these problems “could materially harm [the company’s] business, financial conditions and prospects.” (emphasis added) – The Defender
There is also the question of why the mRNA vaccines from Pfizer and Moderna could have the efficacy the two companies have reported.
Scientists were also not clear as to why the novel mRNA COVID-19 vaccines from Moderna and BioNTect/Pfizer have shown potential high efficacy rates of 90 to 95 percent (from their November press releases), when the prior mRNA drug trials on other pathogens (i.e. other than COVID-19), were not so promising (emphasis added) and had to be abandoned in the early phases of trials. Virologist Margaret Liu stated that it could be due to the “sheer volume of resources” that went into development, or that the vaccines might be “triggering a nonspecific inflammatory response to the mRNA that could be heightening its specific immune response, given that the modified nucleoside technique reduced inflammation but hasn’t eliminated it completely”, and that “this may also explain the intense reactions such as aches and fevers reported in some recipients of the mRNA SARS-CoV-2 vaccines”– Wikipedia
Well one reason also might be that the trials were rigged to make the efficacy look higher than it is.
And there is a strong limiting factor with the mRNA approach to vaccines, as explained in the following quotation.
Unlike DNA molecules, the mRNA molecule is a very fragile molecule that degrades within minutes in an exposed environment, and thus mRNA vaccines need to be transported and stored at very low temperatures. Outside of the human cell, or its drug delivery system, the mRNA molecule is also quickly broken down by the human body. This fragility of the mRNA molecule is a hurdle to the effective efficacy of any mRNA vaccine due to bulk disintegration before it enters the cells, which could lead people to believe, and act as if they are immune when they are not. – Wikipedia
The complicity of the FDA with pharmaceutical companies for the coronavirus vaccine is expressed in the following quotation from a Washington Post article.
FDA decided to allow over 100 of covid-19 test kits be sold OTC even though they had no data on those devices. Sure enough, quite a number of consumers cried foul on the inaccuracy or erroneous results from those tests. Now FDA is stripped of supervisory authority on lab tests and other activities.
And the head of FDA admitted he misspoke about the plasma effectiveness against covid-19.
What’s next? – ct2074
Pfizer, along with the other major pharmaceutical companies has a long history of falsifying clinical trials. Furthermore, something strange is going on regarding the accuracy of the information released by Pfizer, as the following quotation describes.
The Trump administration has openly feuded with Pfizer in recent weeks over its involvement in Operation Warp Speed and the timing of a data release showing its vaccine to be highly effective, but had nonetheless invited CEO Albert Bourla to appear on a panel about the vaccine development process. Moderna CEO Stéphane Bancel was also invited, but neither he nor another company executive will attend.
In a Nov. 20 press conference, Trump accused Pfizer of delaying the release of its final-stage clinical trial data until after Election Day to avoid boosting the president’s reelection odds.
The event appeared to be an effort for the administration to claim credit for the rapid development of a Covid-19 vaccine and to pressure the Food and Drug Administration to move quickly on an authorization. The agency’s commissioner, Stephen Hahn, was twice called to the White House to explain the FDA’s slower-than-desired timetable for issuing emergency use authorizations for Pfizer and Moderna’s vaccines, Axios and Bloomberg reported. – Stat News
Here is a question. Why is the FDA being pressured by the Trump Administration to speed the approval of vaccines? Doesn’t the FDA have its own rules for what it accepts as evidence?
The fact is that the FDA has been dropping its standards since the regulatory body was at its high point of integrity back in the 1970s.
I cover Pfizer in more detail in the article Pfizer Has Promoted its Vaccine for Coronavirus, But How Reliable is Information from Pfizer, but let us move on to Moderna in this article as this is a company that people know much less about.
Moderna is in a different category in that the company has never made any drugs. The following quotation on a Washington Post article brings up a good question.
If you were seriously looking for a vaccine, why would you go with a company that makes vaccines for ten years without ever having a human test? Wouldn’t you rather work with a company that has had a successful trial or 30? – Daniel DePez
In May of 2020, it had a market cap of $29 B, but has never sold a product. And it is not clear that Moderna is doing much science, but instead preferring to talk about science. This is expressed in the following quotation.
While Moderna blitzed the media, it revealed very little information — and most of what it did disclose were words, not data. That’s important: If you ask scientists to read a journal article, they will scour data tables, not corporate statements. With science, numbers speak much louder than words.
STAT asked Moderna for information on the antibody levels it used as a comparator. The response: That will be disclosed in an eventual journal article from NIAID, which is part of the National Institutes of Health.
Durbin was struck by the wording of the company’s statement, pointing to this sentence: “The levels of neutralizing antibodies at day 43 were at or above levels generally seen in convalescent sera.”
“I thought: Generally? What does that mean?” Durbin said. Her question, for the time being, can’t be answered.
Rose said the company should disclose the information. “When a company like Moderna with such incredibly vast resources says they have generated SARS-2 neutralizing antibodies in a human trial, I would really like to see numbers from whatever assay they are using,” he said. – Stat News
Basically, Durbin is saying, in laymen’s terms, that Moderna is running a line of bullshit in its report on its vaccine’s effectiveness.
It doesn’t publish on its work in scientific journals. What is known has been disclosed through press releases. That’s not enough to generate confidence within the scientific community.
“My guess is that their numbers are marginal or they would say more,” Rose said about the company’s SARS-2 vaccine, echoing a suspicion that others have about some of the company’s other work.
“I do think it’s a bit of a concern that they haven’t published the results of any of their ongoing trials that they mention in their press release. They have not published any of that,” Durbin noted.
Still, she characterized herself as “cautiously optimistic” based on what the company has said so far. – Stat News
What company does this sound like? I would say Theranos. They had the same pattern of not publishing information, and making PR announcements, as we cover in the article The Similarity Between Thomas Edison, Elizabeth Holmes, and Hasso Plattner.
Here is what one employee says about working at Moderna.
Unrealistic timelines to get things done in fast-paced timelines. Inexperienced directors in Quality is one of the major drawback of the product outcome. – Glassdoor
And this one…
Currently in between the earlier frenetic approach to product development and now as a public company needing to be more frugal and measured. – Glassdoor
And this one..
The culture is almost non existent but is talked up constantly by upper management. People are stressed and not happy to be at work, are overworked and cut corners which makes me question the quality of some of the work. Everyone constantly complains how absolutely freezing cold it is in the offices. People have to wear jackets inside in the summer. Space is really limited to the point that it feels like a turf war. This is one of the most unwelcoming places I’ve ever worked. Some of the language used and stories I’ve overheard are completely offensive and sound like bullying. It’s completely embarrassing to think this has been going on without anyone stepping in. How does this get overlooked? I guess people don’t reach out to HR anymore because they don’t trust that HR is there for the employee. HR is really there for the company. – Glassdoor
And this one..
Now… if you don’t have a PhD…. Run. It doesn’t matter how much experience you have, how much non-doctoral education you have, how long you’ve served the company, performance, dedication etc. It doesn’t matter….. Run.
The PhD gatekeeping by Moderna is demoralizing to so many key personnel. It creates two classes of employees, and the lower class is disillusioned. I’m convinced this is why Moderna is going to fail. The most important thing to people is respect. Passion and drive are so key for a company like this. When you don’t feel respected, passion for the work is near impossible to hold onto. When you don’t feel respected, you take the easy outs. You do the minimum. When you don’t feel respected, you don’t squeeze in one more experiment before going home. You come in late, you half-ass the documentation, you procrastinate, you order more reagents than you need. – Glassdoor
And this one…
Quality is the biggest team onsite and they make all decisions, without any technical knowledge. Hiring more reviewers, no technical experts. – Glassdoor
And this one..
The arrogance of certain members of management is hard to swallow when you consider the fact that all but one has NEVER developed a drug or have been part of a team that has. The oppressive culture is generally true although some groups experience it worse than others. A lot of good talent left while I was there.
Advice to Management
I wouldn’t really know where to begin. I guess what’s happening at Moderna is true of a lot of biotechs, it just seems more exaggerated. There seem to be a lot of overpaid people who do very little and lean heavily on lesser paid people who have too much to do, solving this issue would be a good start. – Glassdoor
And this one..
They work their employees 24 hours a day, 7 days a week and their turnover rate is extremely high. You see about 25+ employees start at the beginning of the month and by the end, half have been fired and/or quit. Its not even worth getting to know some of the new hires because you know they will be gone sooner rather than later. – Glassdoor
And this one..
Honestly speaking, I had never experienced such an abusive, manipulative and arrogant CEO and the-then-CSO at any company in my entire life. The behavior from management was to blame every thing on others – Glassdoor
And this one..
Moderna is more like a poor man’s Sirtris Pharmaceuticals. Their science is indeed mysterious…ie dark arts.
Advice to Management
Instead of diverting resources on expensive public relations campaigns,(emphasis added) focus on supporting your scientists and staff so the company may someday move forward. Be upfront with new employees about the company’s past and where we are headed now. – Glassdoor
This shows a consistent pattern with Moderna that they are more of a marketing organization than a science organization. Given Moderna’s dysfunctional management, it is hard to see how Moderna can be effective in developing products.
And this one..
Stressful, toxic atmosphere that brings out the worst in everyone. Goddamn awful management team whose plans change daily, who talk all the time about the Moderna “family” in our employee meetings but then fire people on a whim (the rate of employee turnover here has to be seen to be believed). No rational vision for the company beyond maybe convincing somebody who believes all the media hype to buy it so that management can bail with fat checks in their hands.
Advice to Management
Employees need to be respected and valued for their contributions. You can’t build a successful company on the backs of indentured servants. If you put half as much thought and energy into the actual science that goes on in the lab as you do into business deals and exit strategies (emphasis added) you might eventually have something real to sell people that isn’t just self-aggrandizing hype. (emphasis added) – Glassdoor
Again, are we seeing how Moderna’s internal focus on marketing is all-consuming?
And this one..
Bad science, poorly developed methods, blaming technicians for bad results, performance evaluations are laughable. Overall bad environment to work in. – Glassdoor
And this one..
Where to begin? Overtly hostile upper management, exploitative labor practices, inane personality conflicts obliterating professionalism, absurd secrecy bordering on paranoia.
Management has an agenda mapped out quite well and it is fairly transparent- if you’re paying attention. Like all startup environments, their ultimate aim is to be purchased by a larger company,(emphasis added) thus allowing upper management to effectively line their pockets and ride off into the sunset.
They’re more than willing to do this on the backs of the research associates and scientists that have built the company. Moderna takes advantage of all employees below the executive level-(emphasis added) overworked and grossly underpaid, they feel as though they can get away with this type of behavior because of rival companies recently closing their doors. When the bubble bursts, the executives will have handsome rewards while the little guys will be have a place firmly set in the unemployment line. This mentality is not serving them; however.
Within the last six months (review is from 2014), both the CSO and the VP of Manufacturing quit on short notice. Moderna tried to spin it as a shortcoming of those employees; however, both of which worked consistently 100 hours a week only to be on the receiving end of the CEO’s wrath and arrogance. I do wish I could give specific instances regarding the CEO; however, that would be telling of my identity- just take it that most of the things that come out of his mouth are positively flabbergasting and without a doubt abusive. He is unjustly paranoid and prone to wild attacks creating an atmosphere of deceit and hostility. He will pit employees against each other, overtly lie, and then find an ideal scapegoat among the lower employees and hang them out to dry. He is a master of creating a very toxic environment and I genuinely pity the people who are still employed there. Should you decide that you want to work here, just know what you’re getting yourself into. 60 hours a week in the lab is a vacation, that alone, wouldn’t be bad. The sophomoric and soap opera-esque drama that unfolds on a daily basis does; however, have a proclivity for making an 80 hour work week feel like eternity. – Glassdoor
And this one..
Questionable laboratory practices to increase data accumulation. – Experiments were conducted by personnel with dubious scientific backgrounds. – Lab personnel were hostile, possibly due to being overworked. – Very high expectations for very little pay. – Glassdoor
There are repeated references to Moderna not being able to follow lab standards. Most of the coverage of Moderna relates to their innovative approach to vaccines using mRNA. However, the method that is applied by Moderna is one topic. A second and equally important topic is the competence of Moderna. Without competence, the approach that Moderna uses is of little relevance.
This point is reinforced by the following comment.
Bad science practices, blame and finger pointing abound and poor management and lack of planning send reverberations throughout the entire company on a daily basis. – Glassdoor
The following comment describes horrific management.
The culture of the company is very dysfunctional and, frankly, frightening. A lot of people have been fired which management backs up using questionable, if not blatantly false, information. Management takes advantage of employees by overworking them and then excluding them from getting proper recognition and credit—if anything, management actually punishes productive people by taking things away from them. It is common practice for the management team to position employees against each other in what appear to be bizarre mind games.
Advice to Management
abusive and unbelievably disrespectful management team.(emphasis added) Drop the take-it-or-leave-it attitude you have with working with employees because they are all leaving, you’re not that great. – Glassdoor
Observing How Moderna Rigged the Glassdoor Reviews
Reading all of the comments on Glassdoor it is clear that Moderna began reacting to the comments, which the further back you go, the more negative they are. On the more recent comments, Moderna HR/PR began doing damage control and providing responses that attempted to dilute the message of the commenters. And the later reviews had more positive comments that seemed often to be of low content and often the same. This is a telltale sign that the company has demanded that its employees submit positive reviews. This is why the overall average review on Glassdoor for Moderna is inaccurate.
I would also point out that in all the coverage of Moderna in the press, I do not recall running into a single article that points out Moderna’s terrible management history. Given this company’s internal operations, it isn’t easy to see why this company would be qualified to receive funding from the US Government. Moderna is not the only company that applies an mRNA approach to vaccine development.
Faking Innovation and Lying About Taxpayer Support
Another issue is that Moderna has already been caught lying about its support from the US government, as is explained in the following quotation.
Moderna…has failed to disclose government financial support in any of the 126 patents it has filed in its 10-year history, in apparent violation of federal law, according to a new report by activist researchers.
Moderna has not listed that government support in any patents (emphasis added), despite a requirement in the 1980 Bayh-Dole Act that companies disclose in patent applications when they have received government help, KEI said. Moderna also has not disclosed government involvement in any of 154 pending patent applications, KEI’s report said. – The Washington Post
As pointed out by the comment on The Washington Post article, what Moderna did is a first step in cutting the government out of any revenue sharing.
The presence of co-developers in a parent application is important. Especially when your tax dollars went to that development. Any demand for royalties may be harder to prove without it being included in the patent itself. – Alex1952
And by this comment..
Moderna has never followed the law on disclosing federal financial support in any of its 126 patent applications. The company was founded in 2010. It has been happily skating by without these legally mandated and entirely reasonable disclosures and the federal government has happily ignored any enforcement actions.
Drug prices are incredibly high in the US and kept high by many appalling and ridiculous practices. One of the reasons that nothing changes in the pharmaceutical industry is that the American public does not realize how much they have paid for drug research and how often new drugs are created using federal dollars. Yet we pay way much more than we should for drugs and other First World countries pay much less, just because we allow ourselves to be grossly overcharged and other countries are unfair and unscrupulous negotiators who insist, in essence, that the US pay for all drug research while they skirt by for free. – JerseyCityJoan
Moderna is highly connected to the Trump Administration. And Moncef Slaoui, who sat on the board of Moderna and is part of Trump’s coronavirus advisory, has not disclosed his financial ties to Moderna as the following quote explains.
Slaoui’s lack of financial disclosure has attracted negative attention from Democrats on Capitol Hill. Last month, Sens. Elizabeth Warren (Mass.) and Richard Blumenthal (Conn.) and Rep. Pramila Jayapal (Wash.) wrote to Health and Human Services Secretary Alex Azar, blasting Slaoui’s employment status and calling it “a blatant attempt to skirt federal ethics law.” – The Washington Post
Slaoui agreed to sell stock worth $12 million and resign from the board of Moderna, the developer of a leading potential vaccine. But Slaoui insisted on keeping his roughly $10 million stake in his former company, GlaxoSmithKline, another contender in the Operation Warp Speed vaccine race. “I won’t leave those shares because that’s my retirement,” he has said. GlaxoSmithKline, working with Sanofi, has started human trials for a coronavirus vaccine using similar technology to Sanofi’s flu shot. It is supported by up to $2.1 billion from the U.S. government.
“It’s been extremely painful for me that anybody would even think that I took this job to enrich myself or my former colleagues,” Slaoui said. – ProPublica
We bet. It must be tearing up Slaoui inside.
Elizabeth Warren had the following to say about Slaoui.
Congress should strengthen the federal ethics laws to root out this kind of corruption,” Sen. Elizabeth Warren, D-Mass., said at a hearing on Wednesday. “And the first person to be fired should be Dr. Slaoui. The American people deserve to know that COVID-19 decisions are based on science and not on personal greed.” – Pro Publica
Moderna is a horrendous company that has executives who are running a stock scam and has a corrupt agent working as an advisor who is not following ethics rules of divestment in order to reduce his financial conflict of interest. Moderna has a history of lying about its technology and potential since its inception.
In my view, Moderna has zero credibility.
Questioning the Efficiency of the Vaccine is Misinformation?
It is curious that given the highly dubious background of the development of the vaccine, including the FDA being pressured to approve vaccines without sufficient evidence of safety or efficacy, that skepticism regarding the vaccine is referred to as “misinformation,” as shown by the following quotation.
The Food and Drug Administration could vote as soon as Thursday to approve a COVID-19 vaccine developed by Pfizer for emergency use authorization in the United States.
Speaking to NPR this week, FDA head Dr. Stephen Hahn reiterated the government’s commitment to vaccine safety. But public opinion polls suggest many Americans are still skeptical of coronavirus vaccines, and misinformation about them has been spreading online.
Renee DiResta of the Stanford Internet Observatory tells NPR why misinformation often takes hold where people are not necessarily looking for it. – NPR
Remember that the term “misinformation” is used to eventually excuse censoring the information, as we cover in the article How to Differentiate Hate Speech from Love Speech.
The entire strategy of responding to coronavirus is that each country locks down, while a vaccine is developed. This strategy requires that a vaccine is developed quickly. If the vaccine does not arrive, and if the vaccines fail, then the countries are backed into a corner, having to continue unending lockdowns.
Pfizer and Moderna executives are making money for themselves with stock sales.
- The only reason Moderna has received any government money is because of corruption in the Trump Administration. Any analysis of Moderna would have that money going to a different company.
- Both Pfizer and Moderna are unreliable sources of information for whether their product works. The concept is that studies are submitted to the FDA, but the FDA has been aggressively pressured to not apply standards regarding the effectiveness of coronavirus vaccines.
- Both companies are creating expectations that are influencing public policy, and they may be providing exaggerated information about the likelihood of a vaccine that is what countries are basing at least part of their coronavirus strategy.
*Some of the links that this article uses were provided by Markian Jaworsky, who I wanted to thank for alerting me to this topic.